fam76b Antibody

What is FAM76B and why is it important to study using antibodies?

FAM76B is a 39 kDa nuclear speckle-localized protein consisting of 339 amino acids in humans. It contains homopolymeric histidine tracts that serve as targeting signals for nuclear speckles . Although FAM76B was previously a protein with unknown function, recent research has identified it as a negative regulator of inflammation through inhibition of the NF-κB pathway .

FAM76B antibodies are essential tools for studying this protein because:

• They enable detection of FAM76B expression in different tissues and cell types

• They allow for subcellular localization studies through immunohistochemistry and immunofluorescence

• They facilitate the investigation of protein-protein interactions involving FAM76B

• They make possible the assessment of FAM76B's role in inflammatory responses

Strong FAM76B immunolabeling has been observed in the human brain, lymph nodes, and spleen, suggesting its importance in both central nervous system function and immune regulation .

What are the optimal applications for FAM76B antibodies in experimental research?

FAM76B antibodies have proven valuable in multiple experimental applications:

• Western Blotting: For validating FAM76B expression levels in various cell lines, particularly in knockdown and knockout models. For example, FAM76B antibodies were used to confirm FAM76B knockdown in U937 cells through western blot analysis .

• Immunohistochemistry: Custom-made anti-human FAM76B monoclonal antibodies have been used for immunohistochemical staining to detect FAM76B in tissue samples from patients with TBI and neurodegenerative diseases .

• Co-immunoprecipitation: For investigating the interaction between FAM76B and hnRNPA2B1, which is critical for understanding FAM76B's role in regulating inflammation .

• Subcellular Fractionation Studies: FAM76B antibodies can be used to track the nuclear localization of FAM76B and its influence on hnRNPA2B1 translocation .

What are the key considerations for validating FAM76B antibodies?

When validating FAM76B antibodies for research, consider the following:

• Specificity Testing:

  • Use FAM76B knockout (Fam76b-/-) cell lines as negative controls

  • Compare with FAM76B overexpression models as positive controls

  • Perform peptide competition assays to confirm specificity

• Cross-Reactivity Assessment:

  • Test antibodies in multiple species if cross-species studies are planned

  • The antibodies used in research have successfully detected human and mouse FAM76B

• Application-Specific Validation:

  • For western blotting: confirm band size at approximately 39 kDa

  • For immunohistochemistry: include appropriate positive and negative tissue controls

  • For co-immunoprecipitation: validate antibody's ability to maintain protein-protein interactions

How can FAM76B antibodies be utilized to study the relationship between FAM76B and the NF-κB inflammatory pathway?

FAM76B has been demonstrated to inhibit the NF-κB-mediated inflammatory pathway. Researchers can use FAM76B antibodies to investigate this relationship through several approaches:

• Protein Complex Analysis:

  • Co-immunoprecipitation with FAM76B antibodies followed by western blotting for NF-κB components

  • Proximity ligation assays to visualize FAM76B interactions with NF-κB pathway proteins in situ

• Nuclear-Cytoplasmic Fractionation:

  • FAM76B antibodies can be used in conjunction with subcellular fractionation to monitor how FAM76B affects the nuclear translocation of NF-κB components

  • This approach was used to demonstrate that FAM76B affects the cytoplasmic translocation of hnRNPA2B1, which influences NF-κB pathway activation

• Chromatin Immunoprecipitation (ChIP):

  • Use FAM76B antibodies to determine if FAM76B associates with chromatin at NF-κB target gene promoters

• Time-Course Experiments:

  • Monitor FAM76B localization and expression in relation to NF-κB activation following inflammatory stimuli such as LPS treatment

  • Research has shown that following LPS treatment, FAM76B knockout mice exhibit increased inflammatory responses

What methodological approaches are recommended for using FAM76B antibodies in neuroinflammation studies?

When studying neuroinflammation with FAM76B antibodies, consider these methodological approaches:

• Tissue-Specific Immunohistochemistry Protocol:

  • Use 4% paraformaldehyde fixation for brain tissues

  • Employ antigen retrieval techniques to enhance detection

  • Counterstain with neuronal, microglial, or astrocytic markers to evaluate cell-specific expression

• Double Immunofluorescence Staining:

  • Combine FAM76B antibodies with antibodies against inflammatory markers (IL-6, TNFα)

  • Co-stain with hnRNPA2B1 antibodies to visualize co-localization and translocation events

• Ex Vivo Brain Slice Culture Model:

  • Apply FAM76B antibodies in brain slice cultures from FAM76B knockout and wild-type mice to compare inflammatory responses

• In Vivo Imaging:

  • Label FAM76B antibodies with fluorescent tags for in vivo imaging studies of neuroinflammation in animal models

Research has shown that FAM76B plays a significant role in modulating neuroinflammation, particularly in traumatic brain injury models and neurodegenerative diseases like frontotemporal lobar degeneration (FTLD) .

How can FAM76B antibodies be used to investigate the interaction between FAM76B and hnRNPA2B1?

The interaction between FAM76B and hnRNPA2B1 is critical for understanding FAM76B's role in regulating inflammation. Researchers can use the following approaches:

• Co-Immunoprecipitation (Co-IP):

  • Use FAM76B antibodies to pull down protein complexes, then probe for hnRNPA2B1

  • Perform reciprocal Co-IP with hnRNPA2B1 antibodies to confirm interaction

• Proximity Ligation Assay (PLA):

  • Combine FAM76B and hnRNPA2B1 antibodies in PLA to visualize direct interactions in situ

  • Compare PLA signals between normal and inflammatory conditions

• Immunofluorescence Co-localization:

  • Use fluorescently labeled FAM76B and hnRNPA2B1 antibodies to visualize co-localization

  • Track changes in co-localization following inflammatory stimuli

  • Research has shown that FAM76B affects the translocation of hnRNPA2B1 between the nucleus and cytoplasm

• FRET Analysis:

  • Label FAM76B and hnRNPA2B1 antibodies with FRET-compatible fluorophores to detect direct interactions at nanometer scale

What experimental designs are optimal for using FAM76B antibodies in traumatic brain injury (TBI) models?

For TBI research involving FAM76B antibodies, consider these experimental designs:

• Temporal Expression Analysis:

  • Use FAM76B antibodies to track changes in FAM76B expression at different time points after TBI

  • Correlate with inflammatory marker expression and behavioral outcomes

• Regional Analysis:

  • Apply FAM76B antibodies in immunohistochemistry to map regional differences in FAM76B expression post-TBI

  • Compare perilesional areas with distant brain regions

• Cell-Type Specific Expression:

  • Combine FAM76B antibodies with cell-type markers to determine which cells express FAM76B after TBI

  • Compare expression in neurons, astrocytes, microglia, and oligodendrocytes

• Intervention Studies:

  • Use FAM76B antibodies to monitor changes in FAM76B expression following anti-inflammatory interventions

  • Compare wild-type and FAM76B knockout mice in TBI recovery

Research has demonstrated that FAM76B interacts with hnRNPA2B1 in human tissues from patients with acute, organizing, and chronic TBI, suggesting its importance in TBI pathophysiology .

What are the technical considerations for using FAM76B antibodies in studies of cytokine expression?

When using FAM76B antibodies to study inflammatory cytokine expression, consider:

• Cell Stimulation Protocols:

  • For U937 cells: Treatment with 10 ng/mL PMA in association with 10 ng/mL LPS and 20 ng/mL hIFNγ for 48 hours has been shown to induce inflammatory responses

  • For FAM76B knockout U937 cells: Treatment with 1 ng/mL PMA for 48 hours, followed by 10 ng/mL LPS and 20 ng/mL hIFNγ for 24 hours

• Multiplex Cytokine Analysis:

  • Combine FAM76B antibody staining with multiplex cytokine assays to correlate FAM76B expression with multiple cytokine levels

  • Research has shown that FAM76B knockout leads to increased expression of IL6, PTGS2, TNFα, and IL10

• Single-Cell Analysis:

  • Use FAM76B antibodies in flow cytometry or mass cytometry to correlate FAM76B expression with cytokine production at the single-cell level

• Rescue Experiments:

  • For rescuing FAM76B in knockout cell lines, treat U937 cells with 0.5 ng/mL PMA for 24 hours followed by 1 ng/mL LPS and 20 ng/mL hIFNγ for 24 hours

  • For bone marrow-derived macrophages (BMDMs), treat with 1 ng/mL LPS and 20 ng/mL mIFNγ for 24 hours

FAM76B Expression in Various Tissues

Effects of FAM76B Knockout on Inflammatory Cytokine Expression

How can researchers address non-specific binding of FAM76B antibodies?

To minimize non-specific binding:

• Optimization Strategies:

  • Test multiple blocking reagents (BSA, normal serum, commercial blockers)

  • Titrate antibody concentrations to determine optimal dilution

  • Increase wash steps and duration between incubations

• Validation Controls:

  • Include FAM76B knockout (Fam76b-/-) samples as negative controls

  • Use peptide competition assays to confirm specificity

  • Include isotype controls to identify non-specific binding

• Cross-Adsorption:

  • Pre-adsorb antibodies with tissue lysates from FAM76B knockout samples to remove cross-reactive antibodies

• Alternative Antibody Selection:

  • If persistent non-specific binding occurs, consider testing antibodies from different hosts or against different epitopes of FAM76B

What approaches can help resolve discrepancies in FAM76B localization studies?

When facing inconsistent results in FAM76B localization:

• Fixation Method Comparison:

  • Compare paraformaldehyde, methanol, and acetone fixation to determine optimal preservation of FAM76B

  • FAM76B is a nuclear speckle-localized protein, so proper nuclear preservation is essential

• Subcellular Fractionation:

  • Complement immunocytochemistry with biochemical fractionation to confirm localization

  • Compare nuclear and cytoplasmic fractions using western blotting with FAM76B antibodies

• Super-Resolution Microscopy:

  • Employ techniques like STED or STORM for more precise localization within nuclear speckles

  • Co-localize with known nuclear speckle markers

• Live Cell Imaging:

  • Use fluorescently tagged FAM76B constructs to validate antibody-based localization findings

  • Monitor dynamic changes in localization during inflammatory responses

How might FAM76B antibodies contribute to biomarker development for neurodegenerative diseases?

FAM76B has shown interaction with hnRNPA2B1 in tissues from patients with various neurodegenerative diseases . This suggests potential for biomarker development:

• Diagnostic Biomarker Exploration:

  • Develop quantitative assays using FAM76B antibodies to measure FAM76B levels in cerebrospinal fluid or blood

  • Compare FAM76B expression patterns between healthy individuals and those with neurodegenerative diseases

• Prognostic Indicator Development:

  • Investigate whether FAM76B expression correlates with disease progression

  • Determine if FAM76B/hnRNPA2B1 interaction strength predicts disease outcomes

• Treatment Response Monitoring:

  • Use FAM76B antibodies to track changes in FAM76B expression following anti-inflammatory treatments

  • Develop companion diagnostics for immunomodulatory therapeutics

• Multimodal Biomarker Panels:

  • Combine FAM76B antibody-based assays with other neuroinflammatory markers for increased diagnostic accuracy

Research has indicated that "FAM76B dysfunction might be involved in autoimmune processes in frontotemporal lobar degeneration (FTLD)" , suggesting potential applications in this field.

What novel antibody-based approaches could advance understanding of FAM76B post-translational modifications?

To investigate FAM76B post-translational modifications:

• Phospho-Specific Antibodies:

  • Develop antibodies that specifically recognize phosphorylated forms of FAM76B

  • Use phospho-specific antibodies to study how phosphorylation affects FAM76B's anti-inflammatory function

• Ubiquitination Studies:

  • Generate antibodies that detect ubiquitinated FAM76B

  • Investigate how ubiquitination affects FAM76B stability and function in inflammation

• SUMOylation Analysis:

  • Develop antibodies against SUMOylated FAM76B

  • Study how SUMOylation might affect nuclear speckle localization

• Acetylation Research:

  • Create antibodies specific to acetylated forms of FAM76B

  • Examine whether acetylation affects FAM76B's interaction with hnRNPA2B1